Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
D000028:Abortion, Induced; D000818:Animals; D010064:Embryo Implantation / Q000187:drug effects; D004873:Ergolines / Q000494:pharmacology; D004876:Ergot Alkaloids / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D005246:Feedback; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D010906:Pituitary Hormone-Releasing Hormones / Q000502:physiology; D011247:Pregnancy; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism* / Q000502:physiology; D011863:Radioimmunoassay; D051381:Rats
D004873:Ergolines; D004876:Ergot Alkaloids; D010906:Pituitary Hormone-Releasing Hormones; D011388:Prolactin